Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian J Sarembock

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Diabetes Reports|February 7, 2004
Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitusIan J Sarembock
Current Cardiology Reports|May 15, 2012
Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization?Ian J Sarembock, Dean J Kereiakes
The Journal of Experimental Medicine|May 10, 2006
Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependentElena Galkina, Alexandra Kadl, John Sanders, et al.
The American Journal of Pathology|November 30, 2005
Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient miceGuohong Li, John M Sanders, Elizabeth T Phan, et al.
Circulation Research|August 24, 2004
Phosphorylation regulates Id3 function in vascular smooth muscle cellsScott T Forrest, Angela M Taylor, Ian J Sarembock, et al.
Dimensions of Critical Care Nursing : DCCN|May 25, 2006
Predictors of vascular complications post diagnostic cardiac catheterization and percutaneous coronary interventionsCheryl J P Dumont, Arlene W Keeling, Cheryl Bourguignon, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 28, 2004
Percutaneous treatment of focal vs. diffuse in-stent restenosis: a prospective randomized comparison of conventional therapiesMichael Ragosta, Habib Samady, Lawrence W Gimple, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery diseaseMichael Ragosta, Sandra Dee, Ian J Sarembock, et al.
The Journal of Cell Biology|April 6, 2005
The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosisA Wayne Orr, John M Sanders, Melissa Bevard, et al.
American Heart Journal|June 17, 2004
Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteriesMichael Ragosta, Habib Samady, Ross B Isaacs, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Diabetes Reports|February 7, 2004
Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitusIan J Sarembock
Current Cardiology Reports|May 15, 2012
Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization?Ian J Sarembock, Dean J Kereiakes
The Journal of Experimental Medicine|May 10, 2006
Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependentElena Galkina, Alexandra Kadl, John Sanders, et al.
The American Journal of Pathology|November 30, 2005
Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient miceGuohong Li, John M Sanders, Elizabeth T Phan, et al.
Circulation Research|August 24, 2004
Phosphorylation regulates Id3 function in vascular smooth muscle cellsScott T Forrest, Angela M Taylor, Ian J Sarembock, et al.
Dimensions of Critical Care Nursing : DCCN|May 25, 2006
Predictors of vascular complications post diagnostic cardiac catheterization and percutaneous coronary interventionsCheryl J P Dumont, Arlene W Keeling, Cheryl Bourguignon, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 28, 2004
Percutaneous treatment of focal vs. diffuse in-stent restenosis: a prospective randomized comparison of conventional therapiesMichael Ragosta, Habib Samady, Lawrence W Gimple, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery diseaseMichael Ragosta, Sandra Dee, Ian J Sarembock, et al.
The Journal of Cell Biology|April 6, 2005
The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosisA Wayne Orr, John M Sanders, Melissa Bevard, et al.
American Heart Journal|June 17, 2004
Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteriesMichael Ragosta, Habib Samady, Ross B Isaacs, et al.
Pageof 5